IP Library Granted Patent US 11,472,854
Granted Patent B2
US 11,472,854 · App. 16/865,193 · Granted Oct 18, 2022

Insecticidal peptide production, peptide expression in plants and combinations of cysteine rich peptides

Inventors: Robert M. Kennedy (Dexter, MI); William Tedford (Calgary, CA); Christopher Hendrickson (Royal Oak, MI); Robert Venable (Lawrence, MI); Catherine L. Foune (Gobles, MI); John McIntyre (Alto, MI); Alvar R. Carlson (Kalamazoo, MI); Lin Bao (Portage, MI)
Assignee: Vestaron Corporation
C07K14/43518A01N63/50C07K14/43504C12N15/8286C07K2319/55Y02A40/146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,472,854
App. No.
16/865,193
Granted
Oct 18, 2022
Kind
B2
Abstract

New insecticidal proteins, nucleotides, peptides, their expression in plants, methods of producing the peptides, new processes, production techniques, new peptides, new formulations, and new organisms, a process which increases the insecticidal peptide production yield from yeast expression systems. The present invention is also related and discloses selected endotoxins we call cysteine rich insecticidal peptides (CRIPS) which are peptides derived from Bacillus thuringiensis (Bt) and their genes and endotoxins in combination with toxic peptides known as Inhibitor Cystine Knot (ICK) genes and peptides as well as with other types of insecticidal peptides such as trypsin modulating oostatic factor (TMOF) peptide sequences used in various formulations and combinations; of both genes and peptides, useful for the control of insects.

Claims (22)

1. A method of increasing the yield of an insecticidal peptide in a recombinant yeast cell, comprising: operably linking a dipeptide to the insecticidal peptide by adding the codons for the dipeptide to the 5′ end of the transgene nucleotide sequence encoding the insecticidal protein and expressing the resultant dipeptide-insecticidal protein in said yeast cell;

wherein a C-terminus of the dipeptide is operably linked to an N-terminus of the insecticidal peptide;

wherein said dipeptide has one polar amino acid and one non-polar amino acid;

wherein operably linking the dipeptide to the insecticidal peptide converts the insecticidal peptide into a high-production (HP) peptide; and

wherein converting the insecticidal peptide into the HP peptide results in an increased yield of the HP peptide, compared to a yield of the insecticidal peptide before conversion, when said HP peptide or insecticidal peptide are recombinantly expressed in a yeast cell culture expression system.

2. The method of claim 1 , wherein the insecticidal peptide is a Cysteine Rich Insecticidal Protein (CRIP).

3. The method of claim 2 , wherein the CRIP is an Inhibitor Cystine Knot (ICK) motif protein or a non-ICK CRIP.

4. The method of claim 3 , wherein the ICK motif protein is Omega-ACTX-Hv 1 a, Hybrid-ACTX-Hv 1 a, Kappa-ACTX-Hv 1 c.

5. The method of claim 4 , wherein the ICK motif protein has an amino acid sequence that is at least 95% identical to the amino acid sequence set forth in SEQ ID NOs: 593, 661, or 1113.

6. The method of claim 5 , wherein the ICK motif protein has an amino acid sequence as set forth in SEQ ID NOs: 593, 661, or 1113.

7. The method of claim 3 , wherein the non-ICK CRIP is Av2 or Av3.

8. The method of claim 7 , wherein the non-ICK CRIP has an amino acid sequence that is at least 95% identical to the amino acid sequence set forth in SEQ ID NOs: 30 and 1237.

9. The method of claim 8 , wherein the non-ICK CRIP has an amino acid sequence as set forth in SEQ ID NOs: 30 and 1237.

10. The method of claim 1 , wherein the dipeptide comprises a non-polar N-terminal amino acid, and a polar C-terminal amino acid.

11. The method of claim 10 , wherein the non-polar N-terminal amino acid is selected from the group consisting of: G, A, P, V, L, I, F and M.

12. The method of claim 10 , wherein the polar C-terminal amino acid is selected from the group consisting of: S, T, C, N, Q, H, W, and Y.

13. The method of claim 10 , wherein the dipeptide is GS.

14. The method of claim 1 , wherein the HP peptide has an amino acid sequence that is at least 95% identical to the amino acid sequence set forth in SEQ ID NOs: 29, 650, 651, and 652.

15. The method of claim 14 , wherein the HP peptide has an amino acid sequence as set forth in SEQ ID NOs: 29, 650, 651, and 652.

16. The method of claim 1 , wherein the increased yield of the HP peptide is from about 20% to about 400% higher relative to the yield of the insecticidal peptide before conversion.

17. The method of claim 1 , wherein the yeast cell culture expression system comprises a yeast strain selected from a group consisting of the following genera: Kluyveromyces; Pichia; Saccharomyces; Hansenula; Yarrowia ; and Schizosaccharomyces.

18. The method of claim 17 , wherein the yeast strain selected from a group consisting of the following species: Kluyveromyces lactis; Kluyveromyces marxianus; Saccharomyces cerevisiae ; and Pichia pastoris.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2026
From: VESTARON CORPORATION
To: SUTERRA LLC
Reel/Frame 074760/0635 →
RELEASE OF SECURITY INTEREST Recorded May 5, 2026
From: NOVO HOLDINGS A/S
To: VESTARON CORPORATION
Reel/Frame 074568/0448 →
SECURITY INTEREST Recorded Apr 1, 2025
From: VESTARON CORPORATION
To: NOVO HOLDINGS A/S
Reel/Frame 070690/0789 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: KENNEDY, ROBERT M.; TEDFORD, H. WILLIAM; HENDRICKSON, CHRISTOPHER; VENABLE, ROBERT; FOUNE, CATHERINE; MCINTYRE, JOHN; CARLSON, ALVAR; BAO, LIN
To: VESTARON CORPORATION
Reel/Frame 053003/0412 →
Continuity (7)
Division 15390153 · Dec 23, 2016
Division 14383841
Provisional Application 61729905 · Nov 26, 2012
Provisional Application 61698261 · Sep 7, 2012
Provisional Application 61644212 · May 8, 2012
Provisional Application 61608921 · Mar 9, 2012
Related Publication 20200277345A1 · Sep 3, 2020